compound
Retatrutide (24mg Vial) Questions Answered
Retatrutide is a novel triple agonist targeting GLP-1, GIP, and glucagon receptors [1] , studied for substantial weight loss and metabolic improvement in obesity and type 2 diabetes [2] [3] .
Retatrutide (24mg Vial)
Week(s) Weekly Dose (mg) Units (mL) Weeks 1–4 2 mg 20 units (0.20 mL) Weeks 5–8 4 mg 40 units (0.40 mL) Weeks 9–12 8 mg 80 units (0.80 mL) Weeks 13+ 12 mg 120 units (1.20 mL)
Retatrutide is a novel triple agonist targeting GLP-1, GIP, and glucagon receptors [1] , studied for substantial weight loss and metabolic improvement in obesity and type 2 diabetes [2] [3] .
Week(s) Weekly Dose (mg) Units (mL) Weeks 1–4 2 mg 20 units (0.20 mL) Weeks 5–8 4 mg 40 units (0.40 mL) Weeks 9–12 8 mg 80 units (0.80 mL) Weeks 13+ 12 mg 120 units (1.20 mL)
Plan based on a 12–48 week weekly protocol with gradual titration to maintenance dose.
Practical considerations for safe and effective weekly administration. Weekly consistency: Choose a specific day/time for your weekly injection and maintain this schedule throughout the protocol.